MedPath

Boehringer Ingelheim USA Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: telmisartan
Drug: ASA/ER-DP
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
24
Registration Number
NCT02262793

Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers

First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
60
Registration Number
NCT02262546

Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

Completed
Conditions
Hypertension
Interventions
Drug: Micardis®
Drug: MicardisPlus®
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
4814
Registration Number
NCT02262637

Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan/HCTZ fixed dose
Drug: Telmisartan
Drug: Hydrochlorthiazide (HCTZ)
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
30
Registration Number
NCT02262598

Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: BIBR 277 capsule
Drug: BIBR 277 tablet
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
30
Registration Number
NCT02262559

Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: High dose of telmisartan
Drug: Low dose of telmisartan
Drug: HCTZ
First Posted Date
2014-10-13
Last Posted Date
2023-12-08
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
20
Registration Number
NCT02262780

Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan and HCTZ
Drug: Telmisartan
Drug: HCTZ
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
68
Registration Number
NCT02262858

Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan
Drug: Clopidogrel
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
24
Registration Number
NCT02262650

Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: BIBR 277 capsule
Drug: BIBR 277 tablet
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
30
Registration Number
NCT02262585

Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Telmisartan
Drug: Telmisartan/HCTZ fixed combination
Drug: Hydrochlorthiazide (HCTZ)
First Posted Date
2014-10-13
Last Posted Date
2014-10-13
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
36
Registration Number
NCT02262624
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy